Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 30 clinical trials
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP (SAVE)

This is a phase II randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy (ADT) with LHRH agonist or antagonist (arm A) versus

androgens
degarelix
adenocarcinoma
prostatectomy
gonadorelin
  • 15 views
  • 25 Feb, 2022
  • 6 locations
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

The goal of this clinical research is to find if sequential therapy with combined androgen deprivation or hormonal therapy with luteinizing hormone release hormone (LHRH) analog plus a new

  • 0 views
  • 17 Jun, 2022
  • 1 location
PSMA Response in Metastasized Hormone Sensitive Prostate Cancer

PSMA-PET/CT response measurements after LHRH agonist and upfront therapy in men diagnosed with de novo metastasized hormonal sensitive prostate cancer.

  • 0 views
  • 22 Dec, 2021
  • 3 locations
Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients (BonEnza)

-releasing hormone (LHRH) analogue with the use of Whole Boby (WB) DW-MRI.

bone scan
carcinoma
enzalutamide
zoledronic acid
cancer
  • 109 views
  • 02 Mar, 2022
  • 1 location
Management of Castration-Resistant Prostate Cancer With Oligometastases (PCS IX)

participating patients will receive either the standard of care (i.e. LHRH agonist in combination with the new generation of hormonal therapy [Enzalutamide]) or the experimental treatment (i.e. LHRH agonist in

  • 61 views
  • 23 Feb, 2022
  • 11 locations
Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide (ARACOG)

darolutamide 600 mg orally twice daily, in combination with standard LHRH agonist based treatment. Cognitive assessments will be performed using modules from Cambridge Neuropsychological Test Automated Battery

  • 0 views
  • 06 May, 2022
  • 8 locations
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (BAT-RAD)

(mCRPC). Men with mCRPC with progressive disease (radiographically and/or biochemically) who have been treated with gonadotropin-releasing hormone (GnRH)-analogue (LHRH agonists/antagonists) continuously

Accepts healthy volunteers
  • 0 views
  • 11 May, 2022
  • 1 location
Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer

at C1D15 and at D1 of each subsequent 28-day cycle at investigator discretion. LHRH agonist will be used in men and premenopausal women if no oophorectomy has been performed previously. All patients

progesterone receptor
fulvestrant
measurable disease
progesterone
exemestane
  • 0 views
  • 02 Aug, 2021
  • 15 locations
BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy (BEACON)

The purpose of this study is to evaluate the safety and effectiveness of combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) to the pelvis and 6 months of hormonal therapy, otherwise known as short term androgen deprivation therapy (STAD), as treatment for prostate cancer that has come back in …

  • 9 views
  • 04 Mar, 2022
  • 1 location
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer (APRE)

The investigators are conducting this study with men that have prostate cancer and are getting standard of care treatment with the drugs abiraterone acetate and prednisone. The study will follow men with prostate cancer from initiation of participation in the study and for up to 10 years. The reason for …

renal function
androgens
bisphosphonate
dutasteride
serum testosterone
  • 0 views
  • 25 Jul, 2022
  • 2 locations